Product Images Lamotrigine

This is a chart displaying data on the Responder Rate of patients taking Lametrigine ER Tablets versus a placebo. The Responder Rate measures the percentage of patients who experienced 'Improvement' or at least a 'Equal or Greater' response to treatment, as well as the percentage of patients who experienced 'Worsening'. The chart displays different percentages of Responder Rates ranging from 100% to -100%, with 75% and -25% highlighted. There are also percentages listed for the percent of patients who experienced Improvement or Worsening, ranging from 60% to 10%.*

This is a chart comparing the response rates of a placebo group to a group taking Lamotigine Extended release tablets. The response rates are listed in percentages and range from improvement to worsening. The chart is divided into specific response rate intervals and also includes the number of patients in each group (120 for placebo and 116 for Lamotigine tablets).*

This is a description of a medication container for Lamotrigine ER 25mg in a yellow, round tablet form. The text includes instructions to store the tablet at room temperature and to keep it out of reach of children. The container holds 30 tablets and has an expiration date listed as "MM/YY". The manufacturer is Dr. Reddys Laboratories Limited and the National Drug Code (NDC) is 6362982831 08283301523487. There is also some unclear text related to "Dachaged by Buyant Ranch Prcpach Bunbank, 04 91508" which may not be relevant.*

This is a list of different medications with different dosages described by their physical appearance: color, shape, and engravement. The drugs are available in tablet and capsule form. The medications contain from 50mg to 300mg of active ingredients and are identified by engravements such as R717, R718, R719, R720, and R428.*